High-Risk Esophageal GIST: Imaging and Therapeutic Impact on Atypical Metastatic Lesions.

Predrag Sabljak, Aleksandra Djuric-Stefanovic, Miljana Bubanja, Strahinja Odalovic, Nenad Ivanovic, Milica Mitrovic-Jovanovic, Ognjan Skrobic

Abstract read

PubMed Full text at PMC Publisher

In one paragraph

Article in Diagnostics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Predrag SabljakClinic for Digestive Surgery, University Clinical Centre of Serbia, Koste Todorovica Street, No. 6, 11000 Belgrade, Serbia.

Aleksandra Djuric-StefanovicFaculty of Medicine, University of Belgrade, Dr Subotica No. 8, 11000 Belgrade, Serbia.ORCID 0000-0002-5796-835X

Miljana BubanjaCenter for Radiology and Magnetic Resonance Imaging, University Clinical Centre of Serbia, Pasterova No. 2, 11000 Belgrade, Serbia.ORCID 0009-0003-8082-0120

Strahinja OdalovicFaculty of Medicine, University of Belgrade, Dr Subotica No. 8, 11000 Belgrade, Serbia.

Nenad IvanovicClinic for Digestive Surgery, University Clinical Centre of Serbia, Koste Todorovica Street, No. 6, 11000 Belgrade, Serbia.

Milica Mitrovic-JovanovicFaculty of Medicine, University of Belgrade, Dr Subotica No. 8, 11000 Belgrade, Serbia.ORCID 0000-0002-7525-7615

Ognjan SkrobicClinic for Digestive Surgery, University Clinical Centre of Serbia, Koste Todorovica Street, No. 6, 11000 Belgrade, Serbia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This case represents a relatively rare localization of a gastrointestinal stromal tumor involving the distal esophagus with a very unusual mode of metastatic spread to the lymph nodes and bone structures. Diagnostic follow-up showed the effect of tyrosine kinase inhibitor therapy on metastatic lesions, highlighting the necessity of comprehensive diagnostic evaluation in patients with atypical presentations and contributing to the improvement of therapeutic strategies in complex clinical scenarios.

Indexed as

esophagusgastrointestinal stromal tumorsGIST metastasestyrosine kinase inhibitors

Identifiers

PMID40722551

DOI10.3390/diagnostics15141802

PMCPMC12293714

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.